View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Study - CLL17 - Obinutuzumab 1000 / Venetoclax (50/100/200/400), Chronic Lymphocytic Leukemia, cycle 2
Protocol-ID: 1855 V1.0 (Mini), Study-CLL17-OBIN1000/VNTC(50/100/200/400), CLL, C2Study protocol, available to authorized participants only.
Indication(s)
- Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma; ICD-10 C91.1-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 31.10.2021